ConductScience.org, home

Paper7945331

In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol.

Lupo E and 3 others. Biochem Biophys Res Commun, 1994. Cited by 72 papers, by iCite.

Cite this record

ConductScience Library. In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol. Papers, record 7945331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7945331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol.
PubMed
Journal
Biochem Biophys Res Commun
PubMed
Year
1994
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
72
iCite
Relative citation ratio, by iCite
2.47
iCite
Revised in PubMed
2014-11-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lupo EE
2Locher RR
3Weisser BB
4Vetter WW

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntioxidantsMajor topic
Calcium Channel BlockersMajor topic
CopperMajor topic
Lipoproteins, LDLMajor topic
Vitamin EMajor topic
Adult
Amlodipine
Dihydropyridines
Diltiazem
Dose-Response Relationship, Drug
Humans
Isradipine
Oxidation-Reduction
Reference Values
Thiobarbituric Acid Reactive Substances
Verapamil

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.

PMIDTitleJournalYearIn PapersSource
34549160Quantitative Estimation of the Hydrogen-Atom-Donating Ability of 4-Substituted Hantzsch Ester Radical Cations.ACS Omega2021https://conductscience.org/library/papers/34549160PubMed
34070760Novel Combined Antioxidant Strategy against Hypertension, Acute Myocardial Infarction and Postoperative Atrial Fibrillation.Biomedicines2021https://conductscience.org/library/papers/34070760PubMed
33782898Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction.Drug Deliv Transl Res2022https://conductscience.org/library/papers/33782898PubMed
31878229Atherosclerosis and the Capillary Network; Pathophysiology and Potential Therapeutic Strategies.Cells2019https://conductscience.org/library/papers/31878229PubMed
31337127Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation.Int J Mol Sci2019https://conductscience.org/library/papers/31337127PubMed
29382065Electrospun Fibers as a Dressing Material for Drug and Biological Agent Delivery in Wound Healing Applications.Bioengineering (Basel)2018https://conductscience.org/library/papers/29382065PubMed
28123178Clinical roles of calcium channel blockers in ischemic heart diseases.Hypertens Res2017https://conductscience.org/library/papers/28123178PubMed
27900409Perspectives and challenges of antioxidant therapy for atrial fibrillation.Naunyn Schmiedebergs Arch Pharmacol2017https://conductscience.org/library/papers/27900409PubMed
27667708Drug Treatment of Hypertension: Focus on Vascular Health.Drugs2016https://conductscience.org/library/papers/27667708PubMed
268810161,4-Dihydropyridine Derivatives: Dihydronicotinamide Analogues-Model Compounds Targeting Oxidative Stress.Oxid Med Cell Longev2016https://conductscience.org/library/papers/26881016PubMed
26446867Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction.Psychopharmacology (Berl)2016https://conductscience.org/library/papers/26446867PubMed
25237643Wound healing potential of topical amlodipine in full thickness wound of rabbit.Jundishapur J Nat Pharm Prod2014https://conductscience.org/library/papers/25237643PubMed
18406361Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability.Biochim Biophys Acta2008https://conductscience.org/library/papers/18406361PubMed
17051237Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus.J Hum Hypertens2007https://conductscience.org/library/papers/17051237PubMed
12023940Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- and kinin-dependent mechanism.Br J Pharmacol2002https://conductscience.org/library/papers/12023940PubMed
11817973Effects of antihypertensive drugs on endothelial dysfunction: clinical implications.Drugs2002https://conductscience.org/library/papers/11817973PubMed
10981130Antihypertensive drugs and reversing of endothelial dysfunction in hypertension.Curr Hypertens Rep2000https://conductscience.org/library/papers/10981130PubMed
8924055Calcium-channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals.Cardiovasc Drugs Ther1996https://conductscience.org/library/papers/8924055PubMed
8692742Nicanartine improves in vitro resistance of lipoproteins to oxidation.Pharm Res1996https://conductscience.org/library/papers/8692742PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7945331

GET https://conductscience.org/api/papers/v1/7945331/authors